• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

ZOLL Medical Completes Acquisition Of Cardiac Science

Share:

September 3, 2019

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, today confirmed that it has completed the previously announced acquisition of Cardiac Science® Corporation, a leading provider of automated external defibrillators (AEDs), related services, and accessories.

“We are excited about the alignment of our two companies and our combined ability to place lifesaving technology into the hands of more lay rescuers and first responders during medical emergencies,” said Elijah A. White, President of ZOLL Resuscitation. “This acquisition fits well into ZOLL’s vision of providing integrated, innovative acute and resuscitation care for all.”

“Cardiac Science and ZOLL both provide proven AED solutions to broad segments of the public safety market,” he explained. “With Cardiac Science now part of ZOLL, we’ll be able to offer our customers more choices and a stronger AED program management infrastructure to ensure that both families of AEDs are ready when needed.”

Cardiac Science will become part of ZOLL’s Resuscitation division, headquartered in Chelmsford, Massachusetts, but will continue manufacturing in the Deerfield, Wisconsin facility. ZOLL will continue to promote, market, and supply the Powerheart® line of AEDs and Rescue Ready® services as well as ZOLL AEDs and PlusTrac™ program management.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Date: September 03, 2019

Source: ZOLL

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Generate Raises $273M in Series C Financing with New Investors Amgen, NVIDIAGenerate Raises $273M in Series C Financing with New Investors Amgen, NVIDIA
  • With More Than $4.6B in Fundings, Q3 2020 was An Unprecedented Showing from Digital Health InvestorsWith More Than $4.6B in Fundings, Q3 2020 was An Unprecedented Showing from Digital Health Investors
  • TransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to LifeTransMedics Acquires Warm Perfusion EVOSS™ and Cold Perfusion LifeCradle® Technologies from Bridge to Life
  • Relay Therapeutics Snaps up ZebiAI with $85 Million Upfront PaymentRelay Therapeutics Snaps up ZebiAI with $85 Million Upfront Payment
  • Scotland’s Life Sciences Strategy Targets £25bnScotland’s Life Sciences Strategy Targets £25bn
  • NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform
  • What Investors are Saying About Startups in the Age of CoronavirusWhat Investors are Saying About Startups in the Age of Coronavirus
  • Air Force Invests $1.3 Million To Help Military Couples ConceiveAir Force Invests $1.3 Million To Help Military Couples Conceive

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications